Prediction model of RSV-hospitalization in late preterm infants: An update and validation study

Early Human Development

Volumn 95, Issue , 2016, Pages 35-40

  Korsten, Koos ^a   Blanken, Maarten O ^a   Nibbelke, Elisabeth E ^a   Moons, Karel G M ^a   Bont, Louis ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Late preterm; Prediction; Respiratory syncytial virus; Updating; Validation

Indexed keywords

ARTICLE; ASSISTED VENTILATION; BREAST FEEDING; COHORT ANALYSIS; DAY CARE; FEMALE; HOSPITALIZATION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOMOGRAM; PREDICTION; PREDICTOR VARIABLE; PREMATURITY; PROSPECTIVE STUDY; RISK; VALIDATION STUDY; GESTATIONAL AGE; MALE; NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MODELS, STATISTICAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 84959327926     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2016.01.020     Document Type: Article

References (29)

1. Mazur NI, Martinón-Torres F, Baraldi E, Fauroux B, Greenough A, Heikkinen T, et al. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med (Published Online: 24 September 2015).
2. Broadbent L., Groves H., Shields M.D., Power U.F. Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials. Influenza Other Respi Viruses 2015, 9:169-178.
3. Blanken M.O., Koffijberg H., Nibbelke E.E., Rovers M.M., Bont L. Dutch RSVNN. Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study. PLoS One 2013, 8.
4. Ambrose C.S., Anderson E.J., Simoes E.A., Wu X., Elhefni H., Park C.L., et al. Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J 2014, 33:576-582.
5. Law B.J., Langley J.M., Allen U., Paes B., Lee D.S., Mitchell I., et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 2004, 23:806-814.
6. Boyce T.G., Mellen B.G., Mitchel E.F., Wright P.F., Griffin M.R. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000, 137:865-870.
7. Figueras-Aloy J., Carbonell-Estrany X., Quero-Jimenez J., Fernandez-Colomer B., Guzman-Cabanas J., Echaniz-Urcelay I., et al. FLIP-2 study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J 2008, 27:788-793.
8. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., Staat M.A., et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009, 360:588-598.
9. Houben M.L., Bont L., Wilbrink B., Belderbos M.E., Kimpen J.L., Visser G.H., et al. Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study. Pediatrics 2011, 127:35-41.
10. Forbes M.L., Hall C.B., Jackson A., Masaquel A.S., Mahadevia P.J. Comparative costs of hospitalisation among infants at high risk for respiratory syncytial virus lower respiratory tract infection during the first year of life. J Med Econ 2010, 13:136-141.
11. Smyth R.L., Openshaw P.J. Bronchiolitis. Lancet 2006, 368:312-322.
12. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.
13. Jansen A.G., Sanders E.A., Hoes A.W., van Loon A.M., Hak E. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J 2007, 30:1158-1166.
14. Rietveld E., De Jonge H.C., Polder J.J., Vergouwe Y., Veeze H.J., Moll H.A., et al. Anticipated costs of hospitalization for respiratory syncytial virus infection in young children at risk. Pediatr Infect Dis J 2004, 23:523-529.
15. Doering G., Gusenleitner W., Belohradsky B.H., Burdach S., Resch B., Liese J.G. The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age. Pediatr Infect Dis J 2006, 25:1188-1190.
16. Simoes E.A., Carbonell-Estrany X., Fullarton J.R., Liese J.G., Figueras-Aloy J., Doering G., et al. A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study. Respir Res 2008, 9:78.
17. Sampalis J.S., Langley J., Carbonell-Estrany X., Paes B., O'Brien K., Allen U., et al. Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation. Med Decis Making 2008, 28:471-480.
18. RIVM Viral cases. RS-virus 2006-2015, 2015. RIVM, Bilthoven.
19. Janssen K.J., Moons K.G., Kalkman C.J., Grobbee D.E., Vergouwe Y. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol 2008, 61:76-86.
20. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
21. Royston P., Moons K.G., Altman D.G., Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ 2009, 338:b604.
22. Collins G.S., Ogundimu E.O., Altman D.G. Sample size considerations for the external validation of a multivariable prognostic model: a resampling study. Stat Med 2016, 35:214-226.
23. Collins G.S., Reitsma J.B., Altman D.G., Moons K.G. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 2015, 350:g7594.
24. Miller E.K., Williams J.V., Gebretsadik T., Carroll K.N., Dupont W.D., Mohamed Y.A., et al. Host and viral factors associated with severity of human rhinovirus-associated infant respiratory tract illness. J Allergy Clin Immunol 2011, 127:883-891.
25. Lanari M., Prinelli F., Adorni F., Di Santo S., Faldella G., Silvestri M., et al. Maternal milk protects infants against bronchiolitis during the first year of life. Results from an Italian cohort of newborns. Early Hum Dev 2013, 89(Suppl. 1):S51-S57.
26. Chantry C.J., Howard C.R., Auinger P. Full breastfeeding duration and associated decrease in respiratory tract infection in US children. Pediatrics 2006, 117:425-432.
27. Sinha A., Madden J., Ross-Degnan D., Soumerai S., Platt R. Reduced risk of neonatal respiratory infections among breastfed girls but not boys. Pediatrics 2003, 112.
28. Papenburg J., Hamelin M.E., Ouhoummane N., Carbonneau J., Ouakki M., Raymond F., et al. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J Infect Dis 2012, 206:178-189.
29. Sheridan-Pereira M., Murphy J., Sloan J., Crispino G., Leahy A., Corcoran J.D., et al. Respiratory syncytial virus preterm (32-36 completed weeks gestation) risk estimation measure for RSV hospitalization in Ireland: a prospective study. Pediatr Infect Dis J 2015.